Perfusion Tech ApS: Financial statements 2021
CVR: 38238213
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Perfusion Tech ApS (CVR 38238213) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,066,804 and a net result of DKK -2,117,687 compared with DKK -1,485,658 the year before. Equity in the 2021 report amounted to DKK -3,932,376. The company had 4 employees in the financial year.
- Gross Profit
- DKK -1,066,804
- Profit/Loss
- DKK -2,117,687
- Equity
- DKK -3,932,376
- Total Assets
- DKK 1,264,197
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -1.1 mio. | -2.1 mio. | -3.9 mio. | 4 |
| 2020 | - | -1.1 mio. | -1.5 mio. | -1.8 mio. | 3 |
| 2019 | - | -539 t. | -596 t. | -329 t. | 1 |
| 2018 | - | -262 t. | -238 t. | -453 t. | - |
| 2017 | - | -278 t. | -272 t. | -214 t. | - |
Official annual report
Find more companies like Perfusion Tech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Perfusion Tech ApS has published its annual report for 2020. Gross profit came to DKK -1,092,073, and the net result was DKK -1,485,658.
About Perfusion Tech ApS
Perfusion Tech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Perfusion Tech IVS. The management consists of Declan Cassells. The board consists of Declan Cassells. The company is owned by Renew Pharmaceuticals Limited. According to the 2025 annual report, the company had an average of 11 employees. In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity in the 2025 report amounted to DKK -9,640,655.